NKT-3964

N/A

Report date: 2024/09/25 20:00:35
NME

Base Information

Drug NameNKT-3964
Drug Alias NameNKT-3964NKT3964
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclin-dependent kinase 2 degraders
TargetsCyclin-dependent kinase 2
Therapy Area/IndicationsSolid tumoursUterine DiseasesNeoplasm Metastasis +[10] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesNiKang Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesNiKang Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursUterine DiseasesNeoplasm Metastasis +[10] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A